| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.8× | −1.8× | |
| Price / Book | 1.2× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −0.8× | −1.6× | |
| EV / EBITDA | −0.4× | −1.2× | |
| Earnings yield | −123.0% | −14.0% | |
| Free cash flow yield | −131.7% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLY |
| $1,283.29 |
| −1.79% |
| $1.21T |
| 59.6× |
| 77.8% |
| +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.51 | −1.53% | $634.35B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.20 | −0.35% | $502.21B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.35 | −0.38% | $380B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.18 | −2.08% | $355.72B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.18 | −0.70% | $279.63B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.60 | −1.14% | $264.58B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $667.98 | −1.27% | $246.98B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.77 | −1.01% | $239.37B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.46 | −0.46% | $194B | 22.9× | 37.5% | +26.7% |
